Federico Cappuzzo

基本信息

浏览量：241

职业迁徙

个人简介

Federico Cappuzzo, MD, PhD, has been the director of Medical Oncology at AUSL della Romagna, Ravenna, Italy, since April 2016; in January 2017 he became the director of the Hematology and Oncology Department. The author of more than 200 papers, Dr. Cappuzzo is an extremely active member of the IASLC, having served in various leadership and faculty roles for numerous planning committees and meetings. The IASLC Lung Cancer News spoke with Dr. Cappuzzo about checkpoint inhibitors (CPI) in the first- and second-line settings, as well as about the future therapeutic horizon.

研究兴趣

论文共 223 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer: Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical Trials

Mark A Socinski, Robert M Jotte,Federico Cappuzzo, Makoto Nishio, Tony S K Mok, Martin Reck, Gene G Finley, Monika D Kaul, Wei Yu, Nindhana Paranthaman, Ilze Bara, Howard J West

JAMA Oncol（2023）

引用1浏览0WOS引用

Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials

Lee X Li,Federico Cappuzzo, Ignacio Matos, Mark A Socinski, Ashley M Hopkins, Michael J Sorich

The oncologistno. 4 (2023)

引用0浏览0WOS引用

Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4)

Robin Cornelissen, Arsela Prelaj, Sophie Sun, Christina Baik, Mirjana Wollner, Eric B Haura, Hirva Mamdani, Jonathan W Riess,Federico Cappuzzo, Marina C Garassino,John V Heymach, Mark A Socinski,

J Thorac Oncol（2023）

引用0浏览0WOS引用

Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial

Howard Jack West,Mark McCleland,Federico Cappuzzo, Martin Reck, Tony Sk Mok, Robert M Jotte,Makoto Nishio, Eugene Kim, Stefanie Morris,Wei Zou,David Shames, Meghna Das Thakur,

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2022）

引用29浏览0WOS引用

A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting

Irene Terrenato,Cristiana Ercolani,Anna Di Benedetto,Enzo Gallo, Elisa Melucci,Beatrice Casini, Francesca Rollo, Aldo Palange, Paolo Visca,Edoardo Pescarmona, Enrico Melis, Filippo Gallina,

CANCERS（2022）

引用1浏览0WOS引用

Combi-TED: a new trial testing Tedopi ® with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first line

Lorenza Landi, Angelo Delmonte, Andrea Bonetti, Giulia Pasello, Giulio Metro, Francesca Mazzoni, Gloria Borra,Diana Giannarelli, Kalliopi Andrikou, Daniela Mangiola, Stefania Gori, Mario Rosario D'Andrea,

Future oncology (London, England)no. 40 (2022): 4457-4464

引用0浏览0WOS引用

IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain

Naoyuki Nogami,Fabrice Barlesi,Mark A Socinski,Martin Reck,Christian A Thomas,Federico Cappuzzo,Tony S K Mok,Gene Finley,Joachim G Aerts,Francisco Orlandi,Denis Moro-Sibilot,Robert M Jotte,

Journal of Thoracic Oncology（2022）

引用76浏览0WOS引用

Perioperative outcomes of robotic lobectomy for early-stage non-small cell lung cancer in elderly patients

Filippo Tommaso Gallina, Riccardo Tajè, Daniele Forcella, Valeria Gennari, Paolo Visca, Federico Pierconti, Cecilia Coccia,Federico Cappuzzo,Isabella Sperduti,Francesco Facciolo, Enrico Melis

Front Oncol（2022）

引用0浏览0WOS引用

Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences

Fabrizio Tabbò, Lucia Anna Muscarella,Elisa Gobbini,Domenico Trombetta,Stefano Castellana, Angelica Rigutto,Domenico Galetta,Evaristo Maiello, Olga Martelli, Marcello Tiseo,Vieri Scotti, Laura Ghilardi,

European Journal of Cancer（2022）

引用1浏览0WOS引用

Concise Review: Gene of The Month KEAP1-mutant non-small cell lung cancer: the catastrophic failure of a cell-protecting hub

Stefano Scalera, Marco Mazzotta,Clelia Cortile, Eriseld Krasniqi, Ruggero De Maria,Federico Cappuzzo, Gennaro Ciliberto, Marcello Maugeri-Saccà

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (2022)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

其他

论文共 223 篇作者统计合作学者相似作者